Company Analysis BioArctic AB (publ)
1. Summary
Advantages
- Price (18.74 $) is less than fair price (24.64 $)
Disadvantages
- Dividends (0%) are below the sector average (2.17%).
- The stock's return over the last year (-13.66%) is lower than the sector average (-9.33%).
- Current debt level 4.88% has increased over 5 years from 2.1%.
- The company's current efficiency (ROE=-18.24%) is lower than the sector average (ROE=12.15%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| BioArctic AB (publ) | Healthcare | Index | |
|---|---|---|---|
| 7 days | -1.3% | -12.9% | 1.6% |
| 90 days | -18.6% | -14.6% | 4.7% |
| 1 year | -13.7% | -9.3% | 12.2% |
BRCTF vs Sector: BioArctic AB (publ) has slightly underperformed the "Healthcare" sector by -4.33% over the past year.
BRCTF vs Market: BioArctic AB (publ) has significantly underperformed the market by -25.87% over the past year.
Stable price: BRCTF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: BRCTF with weekly volatility of -0.2626% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (18.74 $) is lower than the fair price (24.64 $).
Price significantly below the fair price: The current price (18.74 $) is 31.5% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (99.75) is higher than that of the sector as a whole (38.28).
P/E vs Market: The company's P/E (99.75) is higher than that of the market as a whole (59.99).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (19.99) is higher than that of the sector as a whole (3.52).
P/BV vs Market: The company's P/BV (19.99) is higher than that of the market as a whole (3.41).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (69.53) is higher than that of the sector as a whole (3.74).
P/S vs Market: The company's P/S indicator (69.53) is higher than that of the market as a whole (3.65).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-92.9) is lower than that of the sector as a whole (13.51).
EV/Ebitda vs Market: The company's EV/Ebitda (-92.9) is lower than that of the market as a whole (40.09).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 31.69% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (31.69%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-9.61%).
5.4. ROE
ROE vs Sector: The company's ROE (-18.24%) is lower than that of the sector as a whole (12.15%).
ROE vs Market: The company's ROE (-18.24%) is lower than that of the market as a whole (41.13%).
5.5. ROA
ROA vs Sector: The company's ROA (-15.41%) is lower than that of the sector as a whole (6.06%).
ROA vs Market: The company's ROA (-15.41%) is lower than that of the market as a whole (29.31%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.01%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '2.17%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
